258 related articles for article (PubMed ID: 32392230)
1. Yersinia pseudotuberculosis YopH targets SKAP2-dependent and independent signaling pathways to block neutrophil antimicrobial mechanisms during infection.
Shaban L; Nguyen GT; Mecsas-Faxon BD; Swanson KD; Tan S; Mecsas J
PLoS Pathog; 2020 May; 16(5):e1008576. PubMed ID: 32392230
[TBL] [Abstract][Full Text] [Related]
2. Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.
Fisher ML; Castillo C; Mecsas J
Infect Immun; 2007 Jan; 75(1):429-42. PubMed ID: 17074849
[TBL] [Abstract][Full Text] [Related]
3. Yersinia pseudotuberculosis efficiently escapes polymorphonuclear neutrophils during early infection.
Westermark L; Fahlgren A; Fällman M
Infect Immun; 2014 Mar; 82(3):1181-91. PubMed ID: 24379291
[TBL] [Abstract][Full Text] [Related]
4. Identifying Yersinia YopH-targeted signal transduction pathways that impair neutrophil responses during in vivo murine infection.
Rolán HG; Durand EA; Mecsas J
Cell Host Microbe; 2013 Sep; 14(3):306-17. PubMed ID: 24034616
[TBL] [Abstract][Full Text] [Related]
5. Cell type-specific effects of Yersinia pseudotuberculosis virulence effectors.
Fahlgren A; Westermark L; Akopyan K; Fällman M
Cell Microbiol; 2009 Dec; 11(12):1750-67. PubMed ID: 19681909
[TBL] [Abstract][Full Text] [Related]
6. Yersinia pseudotuberculosis-induced calcium signaling in neutrophils is blocked by the virulence effector YopH.
Andersson K; Magnusson KE; Majeed M; Stendahl O; Fällman M
Infect Immun; 1999 May; 67(5):2567-74. PubMed ID: 10225922
[TBL] [Abstract][Full Text] [Related]
7. SKAP2 is required for defense against
Nguyen GT; Shaban L; Mack M; Swanson KD; Bunnell SC; Sykes DB; Mecsas J
Elife; 2020 Apr; 9():. PubMed ID: 32352382
[No Abstract] [Full Text] [Related]
8. Yersinia enterocolitica YopH-Deficient Strain Activates Neutrophil Recruitment to Peyer's Patches and Promotes Clearance of the Virulent Strain.
Dave MN; Silva JE; Eliçabe RJ; Jeréz MB; Filippa VP; Gorlino CV; Autenrieth S; Autenrieth IB; Di Genaro MS
Infect Immun; 2016 Nov; 84(11):3172-3181. PubMed ID: 27550935
[TBL] [Abstract][Full Text] [Related]
9. The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches.
Logsdon LK; Mecsas J
Infect Immun; 2006 Mar; 74(3):1516-27. PubMed ID: 16495522
[TBL] [Abstract][Full Text] [Related]
10. Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues.
Logsdon LK; Mecsas J
Infect Immun; 2003 Aug; 71(8):4595-607. PubMed ID: 12874339
[TBL] [Abstract][Full Text] [Related]
11. Role of YopK in Yersinia pseudotuberculosis resistance against polymorphonuclear leukocyte defense.
Thorslund SE; Ermert D; Fahlgren A; Erttmann SF; Nilsson K; Hosseinzadeh A; Urban CF; Fällman M
Infect Immun; 2013 Jan; 81(1):11-22. PubMed ID: 23090955
[TBL] [Abstract][Full Text] [Related]
12. Role of Yersinia pseudotuberculosis outer proteins (Yops) in murine humoral immune response.
Maia JM; Monnazzi LG; Medeiros BM
Folia Microbiol (Praha); 2009; 54(3):239-45. PubMed ID: 19649742
[TBL] [Abstract][Full Text] [Related]
13. Yersinia pseudotuberculosis Blocks Neutrophil Degranulation.
Taheri N; Fahlgren A; Fällman M
Infect Immun; 2016 Dec; 84(12):3369-3378. PubMed ID: 27620724
[TBL] [Abstract][Full Text] [Related]
14. Interaction between the Yersinia protein tyrosine phosphatase YopH and eukaryotic Cas/Fyb is an important virulence mechanism.
Deleuil F; Mogemark L; Francis MS; Wolf-Watz H; Fällman M
Cell Microbiol; 2003 Jan; 5(1):53-64. PubMed ID: 12542470
[TBL] [Abstract][Full Text] [Related]
15. Identification of the YopE and YopH domains required for secretion and internalization into the cytosol of macrophages, using the cyaA gene fusion approach.
Sory MP; Boland A; Lambermont I; Cornelis GR
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):11998-2002. PubMed ID: 8618831
[TBL] [Abstract][Full Text] [Related]
16. YopH of Yersinia pseudotuberculosis interrupts early phosphotyrosine signalling associated with phagocytosis.
Andersson K; Carballeira N; Magnusson KE; Persson C; Stendahl O; Wolf-Watz H; Fällman M
Mol Microbiol; 1996 Jun; 20(5):1057-69. PubMed ID: 8809758
[TBL] [Abstract][Full Text] [Related]
17. Type III secretion decreases bacterial and host survival following phagocytosis of Yersinia pseudotuberculosis by macrophages.
Zhang Y; Murtha J; Roberts MA; Siegel RM; Bliska JB
Infect Immun; 2008 Sep; 76(9):4299-310. PubMed ID: 18591234
[TBL] [Abstract][Full Text] [Related]
18.
Sheppe AEF; Santelices J; Czyz DM; Edelmann MJ
Microbiol Spectr; 2021 Sep; 9(1):e0049621. PubMed ID: 34319170
[TBL] [Abstract][Full Text] [Related]
19. The adaptor molecules LAT and SLP-76 are specifically targeted by Yersinia to inhibit T cell activation.
Gerke C; Falkow S; Chien YH
J Exp Med; 2005 Feb; 201(3):361-71. PubMed ID: 15699071
[TBL] [Abstract][Full Text] [Related]
20. Unraveling neutrophil-
Mecsas J
F1000Res; 2019; 8():. PubMed ID: 31327994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
